These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25062081)

  • 1. Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study.
    Gianfagna F; Veronesi G; Guasti L; Chambless LE; Brambilla P; Corrao G; Mancia G; Cesana G; Ferrario MM
    Atherosclerosis; 2014 Sep; 236(1):175-81. PubMed ID: 25062081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men.
    Lind L; Vessby B; Sundström J
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):406-10. PubMed ID: 16306426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study.
    Oksala N; Seppälä I; Hernesniemi J; Lyytikäinen LP; Kähönen M; Mäkelä KM; Reunanen A; Jula A; Ala-Korpela M; Lehtimäki T
    Ann Med; 2013 Mar; 45(2):141-8. PubMed ID: 22524251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.
    Meisinger C; Loewel H; Mraz W; Koenig W
    Eur Heart J; 2005 Feb; 26(3):271-8. PubMed ID: 15618061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
    Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Walldius G; Hamsten A; Hellénius ML; Fisher RM
    Eur Heart J; 2007 Nov; 28(21):2637-43. PubMed ID: 17766927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid and apolipoproteins (ApoAI, ApoB, Apo CIII, ApoE) disturbance in hemodialysis (HD) and renal transplant (Tx) patients.
    Janicki K; Solski J; Janicka L; Kimak E; Bednarek-Skublewska A; Stettner S; Molas G
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):459-66. PubMed ID: 16146031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reference intervals for six lipid analytes in 8-14 year-old school children from three different ethnical groups in the Hulun Buir area of China.
    Du Y; Sun H; Li Y; Shi X; Pei D; Qi D; Wang B
    Clin Lab; 2014; 60(8):1295-300. PubMed ID: 25185414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
    Rasouli M; Kiasari AM
    Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.
    Nomikos T; Panagiotakos D; Georgousopoulou E; Metaxa V; Chrysohoou C; Skoumas I; Antonopoulou S; Tousoulis D; Stefanadis C; Pitsavos C;
    Lipids Health Dis; 2015 Sep; 14():108. PubMed ID: 26370413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.
    Straczek C; Tafflet M; Barberger-Gateau P; Bertrand M; Dupuy AM; Ducimetière P; Empana JP
    Atherosclerosis; 2011 Feb; 214(2):426-31. PubMed ID: 21129746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
    Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
    JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
    Rasouli M; Kiasari AM; Mokhberi V
    Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of lipids and apolipoproteins in three cultures.
    Solhpour A; Parkhideh S; Sarrafzadegan N; Asgary S; Williams K; Jungner I; Aastveit A; Walldius G; Sniderman A
    Atherosclerosis; 2009 Nov; 207(1):200-7. PubMed ID: 19766218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study.
    Koskinen J; Magnussen CG; Würtz P; Soininen P; Kangas AJ; Viikari JS; Kähönen M; Loo BM; Jula A; Ahotupa M; Lehtimäki T; Ala-Korpela M; Juonala M; Raitakari OT
    Eur J Prev Cardiol; 2012 Dec; 19(6):1296-303. PubMed ID: 21960651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoproteins A-I and B-markers in coronary risk evaluation.
    Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
    Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
    Sniderman AD; Jungner I; Holme I; Aastveit A; Walldius G
    J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.